Scientists discover workings of first promising Marburg virus treatment

  • With a mortality rate of up to 88 percent, Marburg virus can rip through a community in days. In 2005, an outbreak of Marburg virus struck a pediatric ward in the country of Angola. With no treatment available, doctors struggled to help as the virus killed 329 of 374 infected patients.

Now, scientists at The Scripps Research Institute (TSRI) have discovered the workings of the first promising treatment for Marburg virus, a pathogen with the same pandemic potential as Ebola virus. The research builds on previous studies showing that an antibody called MR191 can neutralize Marburg—though no one knew exactly how it targeted the virus.
For the new study, TSRI scientists created a map of the virus' structure and revealed through high-resolution imaging how MR191 targets and neutralizes the virus. This antibody—or a strategy to elicit this antibody in patients—could finally give doctors a way to successfully treat the disease.
"This is the first antibody therapeutic found that could treat Marburg," says Erica Ollmann Saphire, PhD, a TSRI professor and senior author of the study, published today in the journal Cell Host & Microbe.
"With this new structure, we can start to see how this treatment works," adds Liam King, a TSRI graduate student and first author of the study. "We have also learned new things about the virus itself that could lead to new treatments and vaccines."
The scientists used a high-resolution imagingtechnique called x-ray crystallography and found that MR191 neutralizes the virus by mimicking the host receptor and plugging into a spot on the viral surface called the receptor binding site. With this site occupied, the virus can no longer attach itself to human cells and spread infection.

TSRI Graduate Student Liam King and Professor Erica Ollmann Saphire, PhD. Credit: Madeline McCurry-Schmidt / The Scripps Research Institute
The imaging also shows part of the architecture of a "wing" that sticks out of the side of the viral structure. The wing was particularly important for researchers to map since it appears to be one of only two known sites where protective human antibodies can bind.
As researchers draw up the battle plans against Marburg virus, they are noticing important ways Marburg differs from its close relative, Ebola virus. The new study reveals that, unlike the wing on Ebola virus, Marburg's wing folds around the outside of the glycoprotein spike.
"That finding and others in this structure tell us that Marburg is constructed differently from its cousin, the Ebola virus," says Ollmann Saphire. "That means the therapeutic strategy for one may need to be different from the other."
Another key difference: While both viruses use a structure called a glycan cap to shield the vulnerable receptor binding site from the human immune system, the new study reveals that MR191 can get around the glycan cap on Marburg virus—an ability scientists have not observed for any antibodies against Ebola virus.
Ollmann Saphire says the next step is to study how known mutations in Marburg evade such antibodies and to use that information to devise second-line treatments. Soon, the team hopes to see the antibody therapeutic go into clinical trials. As part of this effort, study collaborators at Vanderbilt University have licensed MR191 to a commercial partner.
More information: "The Marburg virus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding," Cell Host & Microbe (2018).
Provided by: The Scripps Research Institute
Explore further
•
Researchers find new antibody weapons against Marburg virus
Jun 29, 2015
A new study led by scientists at The Scripps Research Institute (TSRI) identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop ...

•
Researchers inhibit Ebola virus
Dec 29, 2017
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus ...

•
Ebola-like Marburg virus kills two in Uganda: official
Oct 19, 2017
Two people have died from the Marburg virus in eastern Uganda, in the country's first outbreak of the deadly Ebola-like pathogen in three years, the health ministry said Thursday.

•
Uganda declares itself free of Ebola-like Marburg virus
Nov 11, 2014
Ugandan health officials on Tuesday declared the country free of the Ebola-like Marburg virus after completing a 42-day surveillance period under World Health Organization (WHO) rules.

•
Uganda Marburg virus outbreak is contained: WHO (Update)
Dec 08, 2017
Uganda has contained an outbreak of the Ebola-like Marburg virus weeks after it emerged, the World Health Organization said Friday, praising improved response systems since the disastrous West African Ebola epidemic.



Comments

Post a Comment

Popular posts from this blog

Breast cancer charities: How to make an impact

Breast cancer charities: How to make an impact With thousands of charities competing for donations, it can be difficult to know where a financial gift to a good cause will make the biggest impact. This article outlines the top  breast cancer  charities in the United States and their specific contributions to the cause, plus other factors to keep in mind before donating. The history of the pink ribbon The pink ribbon is a symbol of breast cancer and is often sold to raise money for breast cancer charities. Breast cancer activist and survivor Charlotte Hayley inspired the design of the pink ribbon, which is still in use today. Hayley initially handed out peach-coloured looped ribbons that she made herself with a card stating: "The National Cancer Institute's annual budget is $1.8 billion, only 5 percent goes for  cancer  prevention. Help us wake up our legislators and America by wearing this ribbon." In 1991, the Susan G. Komen Breast Cancer Foundati...
Read more

Lung cancer and cough: What is the connection?

Image
Lung cancer and cough: What is the connection? Everyone has experienced a nagging cough after a cold or needed to cough while in a quiet room. Despite these problems, coughing actually serves a very valuable and useful purpose. Coughing is a protective action, helping the lungs clear out potential germs or harmful objects.  Sometimes, however, that cough is not linked to a cold or infection and can linger for weeks to months at a time. This may lead people to wonder or worry that their cough is a sign of something more serious, such as  lung cancer . This article takes a look at the connection between coughing and lung cancer, including when someone should see a doctor. Coughing and lung cancer A cough associated with lung cancer may be either dry or wet. Not every a cough signifies the presence of lung cancer. However, many people do complain of a chronic cough or a "cough that just won't go away" at the time of their diagnosis. If a cough is associate...
Read more

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management

For people with Type 2 diabetes, there is an additional incentive for keeping the disease under management  Research shows a possible link between diabetes and cognitive decline, including increased risk for Alzheimer’s disease and vascular dementia. The scientific reason behind the link between diabetes and brain health is complex. Some scientists believe people with diabetes may also have insulin resistance or insulin deficiency that could damage brain cells enough to cause memory loss. Studies are underway to understand why 80 percent of people with Alzheimer’s disease also have some form of diabetes or disturbed glucose metabolism. However, so far, longitudinal research has not produced a consensus view regarding the link between blood glucose levels and cognitive impairment. Meanwhile, in South Florida, medical professionals are working with diabetic patients to minimize the risk of cognitive decline through a variety of methods that include lifestyle, medical and mental-...
Read more